Literature DB >> 1907616

Lysosomal alpha-N-acetylgalactosaminidase deficiency, the enzymatic defect in angiokeratoma corporis diffusum with glycopeptiduria.

T Kanzaki1, A M Wang, R J Desnick.   

Abstract

Recently a novel case of angiokeratoma corporis diffusum with glycoaminoaciduria was described in a 46-yr-old Japanese woman. Known causes of the cutaneous manifestation were eliminated by enzyme analyses, and further characterization of the accumulated urinary O-linked sialopeptides revealed identity to those excreted by patients with an infantile neuroaxonal dystrophy due to lysosomal alpha-N-acetylgalactosaminidase deficiency. Investigation of the alpha-N-acetylgalactosaminidase activity and protein in the proband revealed less than 2% of normal activity and the absence of detectable immunoreactive enzyme protein, findings comparable to those in the patients with infantile neuroaxonal dystrophy and alpha-N-acetylgalactosaminidase deficiency. In addition, the proband's unaffected offspring had half-normal levels of alpha-N-acetylgalactosaminidase activity, consistent with this enzymatic deficiency being the primary metabolic defect in this autosomal recessive trait. Ultrastructural examination of skin and blood cells from the adult proband revealed the presence of prominent lysosomal inclusions containing diffuse amorphous and filamentous material. In contrast, these morphologic findings were not observed in the nonneural tissues from patients with infantile neuroaxonal dystrophy and alpha-N-acetylgalactosaminidase deficiency. These studies document the occurrence of two forms of alpha-N-acetylgalactosaminidase deficiency and sialopeptiduria, a severe infantile-onset form of neuroaxonal dystrophy without angiokeratoma or visceral lysosomal inclusions and an adult-onset form characterized by angiokeratoma, extensive lysosomal accumulation of sialoglycopeptides and the absence of detectable neurologic involvement.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1907616      PMCID: PMC295421          DOI: 10.1172/JCI115357

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

1.  Human beta-mannosidase deficiency.

Authors:  D A Wenger; E Sujansky; P V Fennessey; J N Thompson
Journal:  N Engl J Med       Date:  1986-11-06       Impact factor: 91.245

2.  Fluorometric assay of proteins in the nanogram range.

Authors:  P Böhlen; S Stein; W Dairman; S Udenfriend
Journal:  Arch Biochem Biophys       Date:  1973-03       Impact factor: 4.013

3.  Schindler disease: the molecular lesion in the alpha-N-acetylgalactosaminidase gene that causes an infantile neuroaxonal dystrophy.

Authors:  A M Wang; D Schindler; R Desnick
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

4.  A method for the rapid detection of urinary glycopeptides in alpha-N-acetylgalactosaminidase deficiency and other lysosomal storage diseases.

Authors:  D Schindler; T Kanzaki; R J Desnick
Journal:  Clin Chim Acta       Date:  1990-09       Impact factor: 3.786

5.  Human alpha-N-acetylgalactosaminidase-molecular cloning, nucleotide sequence, and expression of a full-length cDNA. Homology with human alpha-galactosidase A suggests evolution from a common ancestral gene.

Authors:  A M Wang; D F Bishop; R J Desnick
Journal:  J Biol Chem       Date:  1990-12-15       Impact factor: 5.157

6.  Novel lysosomal glycoaminoacid storage disease with angiokeratoma corporis diffusum.

Authors:  T Kanzaki; M Yokota; N Mizuno; Y Matsumoto; Y Hirabayashi
Journal:  Lancet       Date:  1989-04-22       Impact factor: 79.321

7.  Niemann-Pick disease: a frequent missense mutation in the acid sphingomyelinase gene of Ashkenazi Jewish type A and B patients.

Authors:  O Levran; R J Desnick; E H Schuchman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

8.  Gaucher disease: genetic heterogeneity within and among the subtypes detected by immunoblotting.

Authors:  D Fabbro; R J Desnick; G A Grabowski
Journal:  Am J Hum Genet       Date:  1987-01       Impact factor: 11.025

9.  Isolation and structural characterization of sialic-acid-containing glycopeptides of the O-glycosidic type from the urine of two patients with an hereditary deficiency in alpha-N-acetylgalactosaminidase activity.

Authors:  H U Linden; R A Klein; H Egge; J Peter-Katalinic; J Dabrowski; D Schindler
Journal:  Biol Chem Hoppe Seyler       Date:  1989-07

10.  alpha-N-acetylgalactosaminidase deficiency, a new lysosomal storage disorder.

Authors:  O P van Diggelen; D Schindler; R Willemsen; M Boer; W J Kleijer; J G Huijmans; W Blom; H Galjaard
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

View more
  5 in total

1.  Structural and immunocytochemical studies on alpha-N-acetylgalactosaminidase deficiency (Schindler/Kanzaki disease).

Authors:  Hitoshi Sakuraba; Fumiko Matsuzawa; Sei-Ichi Aikawa; Hirofumi Doi; Masaharu Kotani; Hiroshi Nakada; Tomoko Fukushige; Tamotsu Kanzaki
Journal:  J Hum Genet       Date:  2003-12-19       Impact factor: 3.172

2.  The molecular lesion in the alpha-N-acetylgalactosaminidase gene that causes angiokeratoma corporis diffusum with glycopeptiduria.

Authors:  A M Wang; T Kanzaki; R J Desnick
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

3.  Human alpha-N-acetylgalactosaminidase (alpha-NAGA) deficiency: new mutations and the paradox between genotype and phenotype.

Authors:  J L Keulemans; A J Reuser; M A Kroos; R Willemsen; M M Hermans; A M van den Ouweland; J G de Jong; R A Wevers; W O Renier; D Schindler; M J Coll; A Chabas; H Sakuraba; Y Suzuki; O P van Diggelen
Journal:  J Med Genet       Date:  1996-06       Impact factor: 6.318

Review 4.  Lysosomal storage diseases.

Authors:  Carlos R Ferreira; William A Gahl
Journal:  Transl Sci Rare Dis       Date:  2017-05-25

5.  Multiple exo-glycosidases in human serum as detected with the substrate DNP-α-GalNAc. I. A new assay for lysosomal α-N-acetylgalactosaminidase.

Authors:  Simon P J Albracht; Erik Allon; Johannes van Pelt
Journal:  BBA Clin       Date:  2017-10-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.